Insider · CIK 0001774478

Viehbacher Christopher

Reports to the SEC for 3 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001774478

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-07	BRVEBraveheart Bio, Inc.P Purchase	Director	PPurchase	+83.3K sh	$18.00	+$1.5M	609,519
2026-08-05	BRVEBraveheart Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2026-02-13	BIIBBIOGEN INC. · Restricted Stock UnitA Award	Director, President and CEO	AAward	+38K sh	—	—	38,015
2026-02-06	BIIBBIOGEN INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+9,008 sh	—	—	25,451
2026-02-06	BIIBBIOGEN INC.F Tax Payment	Director, President and CEO	FTax Payment	−4,356 sh	$201.18	−$876K	21,095
2026-02-06	BIIBBIOGEN INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+15.5K sh	—	—	36,548
2026-02-06	BIIBBIOGEN INC.F Tax Payment	Director, President and CEO	FTax Payment	−6,624 sh	$201.18	−$1.33M	29,924
2026-02-06	BIIBBIOGEN INC. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−9,008 sh	—	—	9,009
2026-02-06	BIIBBIOGEN INC. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−15.5K sh	—	—	30,907
2025-12-01	BIIBBIOGEN INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+7,040 sh	—	—	19,847
2025-12-01	BIIBBIOGEN INC.F Tax Payment	Director, President and CEO	FTax Payment	−3,404 sh	$177.78	−$605K	16,443
2025-12-01	BIIBBIOGEN INC. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−7,040 sh	—	—	0
2025-02-07	BIIBBIOGEN INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+9,008 sh	—	—	16,008
2025-02-07	BIIBBIOGEN INC.F Tax Payment	Director, President and CEO	FTax Payment	−3,201 sh	$141.35	−$452K	12,807
2025-02-07	BIIBBIOGEN INC. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−9,008 sh	—	—	18,017
2025-02-06	BIIBBIOGEN INC. · Restricted Stock UnitA Award	Director, President and CEO	AAward	+46.4K sh	—	—	46,360
2024-02-07	BIIBBIOGEN INC. · Restricted Stock UnitA Award	Director, President and CEO	AAward	+27K sh	—	—	27,025
2022-12-01	BIIBBIOGEN INC. · Stock OptionA Award	Director, President and CEO	AAward	+80.5K sh	—	—	80,522
2022-12-01	BIIBBIOGEN INC. · Restricted Stock UnitA Award	Director, President and CEO	AAward	+7,040 sh	—	—	7,040
2022-12-01	BIIBBIOGEN INC. · Performance Stock UnitA Award	Director, President and CEO	AAward	+46K sh	—	—	45,998

Recent filings

Accepted (ET)
Aug 74
Viehbacher Christopher0001470831-26-000801
SEC(opens sec.gov)
Feb 174
Viehbacher Christopher0000875045-26-000035
SEC(opens sec.gov)
Feb 104
Viehbacher Christopher0000875045-26-000024
SEC(opens sec.gov)
Dec 34
Viehbacher Christopher0000875045-25-000052
SEC(opens sec.gov)
Feb 104
Viehbacher Christopher0001127602-25-003962
SEC(opens sec.gov)
Feb 94
Viehbacher Christopher0001127602-24-004302
SEC(opens sec.gov)
Dec 54
Viehbacher Christopher0001127602-22-026909
SEC(opens sec.gov)

Companies

Address

C/O BRAVEHEART BIO, INC. ONE LETTERMAN DR., BLDG. A, SUITE A4-300

SAN FRANCISCO, CA, 94129